Sienna Biopharmaceuticals, Inc. Business Finance Contracts & Agreements
11 Contracts & Agreements
- Exchange Agreements (3 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (2)
- Stock Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (2)
- Underwriting Agreement, dated as of February 20, 2019, among Sienna Biopharmaceuticals, Inc., Cowen and Company, LLC and BMO Capital Markets Corp., as representative of the... (Filed With SEC on February 22, 2019)
- First Amendment to Loan and Security Agreement, dated as of January 28, 2019 between Silicon Valley Bank and Sienna Biopharmaceuticals, Inc (Filed With SEC on January 30, 2019)
- Warrant to Purchase Common Stock, dated as of January 28, 2019, by and between Life Science Loans II, LLC and Sienna Biopharmaceuticals, Inc (Filed With SEC on January 30, 2019)
- Warrant to Purchase Common Stock, dated as of January 28, 2019, by and between Silicon Valley Bank and Sienna Biopharmaceuticals, Inc (Filed With SEC on January 30, 2019)
- Loan and Security Agreement, dated as of June 29, 2018 between Silicon Valley Bank and Sienna Biopharmaceuticals, Inc (Filed With SEC on July 2, 2018)
- SIENNA BIOPHARMACEUTICALS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE,SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on July 17, 2017)
- Confidential Treatment Requested by Sienna Biopharmaceuticals, Inc. AMENDED AND RESTATED EXCLUSIVE SUPPLY AND LICENSE AGREEMENT by and between NANOCOMPOSIX,INC. a California... (Filed With SEC on July 17, 2017)
- SIENNA BIOPHARMACEUTICALS, INC. Shares of Common Stock Underwriting Agreement (Filed With SEC on July 17, 2017)
- SIENNA BIOPHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT April 12, 2017 TABLE OF CONTENTS (Filed With SEC on July 3, 2017)
- Confidential Treatment Requested by Sienna Biopharmaceuticals, Inc. AMENDED AND RESTATED EXCLUSIVE SUPPLY AND LICENSE AGREEMENT by and between NANOCOMPOSIX,INC. a California... (Filed With SEC on July 3, 2017)
- Confidential Treatment Requested by Sienna Biopharmaceuticals, Inc. 6 December 2016 THE VENDORS details ofwhom are set out in Schedule 1 (as Vendors) and SIENNABIOPHARMACEUTICALS,... (Filed With SEC on July 3, 2017)
